Study Evaluating the Safety and Efficacy of an ECM Hydrogel for the Treatment of Anorectal Fistulas
Part of paid clinical trials in Lebanon, New Hampshire.
- Sponsor
- ECM Therapeutics, Inc.
- Study ID
- NCT07035925
- Status
- Recruiting
Conditions
- Fistula in Ano
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- ECMT-100 — DEVICEColloidal hydrogel
Study Details
Safety and Efficacy of ECMT-100 for the Treatment of Anorectal Fistulas
Key Dates
- Start date
- Nov 24, 2025
- Status verified
- Dec 2025
- Primary completion
- Feb 24, 2027
- Completion
- Apr 24, 2028
Study Design
- Enrollment
- 10 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: TreatmentECMT-100 Subjects will be followed for 12 months following last treatment with ECMT-100. Subjects are eligible for one repeat treatment as determined by the clinician/investigator at or prior to the 6-month visit.
Primary Outcome Measure
Adverse Events [ Time Frame: 12 months from treatment ]
Central Contacts
- Julie Cramer330-507-0801
- Cynthia Berringer412-638-9986
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | Madison Duclos 603-653-3607 |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15237 |